دورية أكاديمية
أعرض في EDS

Influenza H1N1 infection in immunocompromised host: A concise review.

التفاصيل البيبلوغرافية
العنوان: Influenza H1N1 infection in immunocompromised host: A concise review.
المؤلفون: Harish MM; Department of Critical Care Medicine, Narayana Hrudayalaya, Bengaluru, Karnataka, India., Ruhatiya RS; Department of Critical Care Medicine, Narayana Hrudayalaya, Bengaluru, Karnataka, India.
المصدر: Lung India : official organ of Indian Chest Society [Lung India] 2019 Jul-Aug; Vol. 36 (4), pp. 330-336.
نوع المنشور: Journal Article; Review
اللغة: English
بيانات الدورية: Publisher: Medknow Country of Publication: India NLM ID: 8405380 Publication Model: Print Cited Medium: Print ISSN: 0970-2113 (Print) Linking ISSN: 09702113 NLM ISO Abbreviation: Lung India Subsets: PubMed not MEDLINE
أسماء مطبوعة: Publication: Jan./Mar. 2011-: Mumbai, India : Medknow
Original Publication: Bombay : Indian Chest Society
مستخلص: Influenza A (H1N1) infection has a propensity to infect an immunocompromised host (ICH). These patients experience more severe manifestations and related complications with increased mortality. Influenza A (H1N1) infection in ICH differs from non-ICH in terms of clinical features, range of complications, radiological features, treatment response, and outcome. Radiology may show higher number of lesions but with no or minimal corresponding clinical manifestations. Coinfection with streptococci, staphylococci, and Aspergillus further increases mortality. Antiviral resistance compounds the overall picture despite optimal regimen. Use of steroids is detrimental. Extracorporeal membrane oxygenation (ECMO) is usually avoided in ICH. However, ICH groups with influenza A (H1N1) infection complicated by acute respiratory distress syndrome who have received ECMO have recorded mortality up to 61%. Nevertheless, evidence-based recommendation on use of ECMO in ICH is lacking. Annual inactivated influenza vaccine is recommended for most ICH groups with a few exceptions and for their close contacts. Hygiene measures greatly contribute to reducing disease burden. High index of suspicion for influenza A (H1N1) infection in ICH, early antiviral therapy, and treatment of coinfection is recommended. With the threat of transmission of resistant viral strains from ICH to the community, apart from treatment, preventive measures such as vaccination and hygienic practices have a significant role. Through this review, we have attempted to identify clinical and radiological peculiarities in ICH with influenza A (H1N1) infection, treatment guidelines, and prognostic factors. Influenza A (H1N1) infection in ICH may remain clinically silent or mild.
Competing Interests: None
References: Transplantation. 2000 Aug 15;70(3):543-5. (PMID: 10949202)
Arch Intern Med. 2001 Feb 12;161(3):441-6. (PMID: 11176770)
Clin Infect Dis. 2004 Nov 1;39(9):1300-6. (PMID: 15494906)
J Infect Dis. 2006 Mar 15;193(6):760-4. (PMID: 16479508)
Clin Infect Dis. 2009 Jan 1;48 Suppl 1:S3-13. (PMID: 19067613)
Science. 2009 Jul 10;325(5937):197-201. (PMID: 19465683)
Lancet Infect Dis. 2009 Jun;9(6):384-92. (PMID: 19467478)
Nature. 2009 Jun 18;459(7249):931-9. (PMID: 19525932)
Ann Intern Med. 2009 Oct 6;151(7):437-46. (PMID: 19652172)
MMWR Morb Mortal Wkly Rep. 2009 Aug 21;58(32):893-6. (PMID: 19696719)
N Engl J Med. 2009 Nov 12;361(20):1945-52. (PMID: 19745214)
N Engl J Med. 2009 Dec 17;361(25):2405-13. (PMID: 19745216)
Lancet. 2009 Oct 17;374(9698):1351-63. (PMID: 19762075)
N Engl J Med. 2009 Nov 12;361(20):1925-34. (PMID: 19815860)
Intensive Care Med. 2010 Feb;36(2):373-4. (PMID: 19820915)
JAMA. 2009 Nov 4;302(17):1872-9. (PMID: 19822627)
JAMA. 2009 Nov 4;302(17):1888-95. (PMID: 19822628)
JAMA. 2009 Nov 4;302(17):1896-902. (PMID: 19887665)
AJR Am J Roentgenol. 2009 Dec;193(6):1488-93. (PMID: 19933638)
Blood. 2010 Feb 18;115(7):1331-42. (PMID: 20009037)
J Infect Dis. 2010 May 1;201(9):1397-403. (PMID: 20350163)
Crit Care. 2010;14(2):139. (PMID: 20392286)
JAMA. 2010 Apr 21;303(15):1517-25. (PMID: 20407061)
Ann Intern Med. 2010 May 18;152(10):687-8. (PMID: 20479037)
Clin Infect Dis. 2010 Jul 1;51(1):70-2. (PMID: 20482372)
Lancet Infect Dis. 2010 Aug;10(8):521-6. (PMID: 20620116)
Biol Blood Marrow Transplant. 2011 Apr;17(4):566-73. (PMID: 20708084)
AIDS. 2010 Nov 27;24(18):2867-9. (PMID: 20802295)
AIDS. 2010 Oct 23;24(16):2461-7. (PMID: 20827165)
Transplantation. 2010 Dec 27;90(12):1458-62. (PMID: 20921933)
Am J Respir Crit Care Med. 2010 Oct 15;182(8):1089-90. (PMID: 20947911)
Clin Infect Dis. 2011 Feb 1;52(3):301-12. (PMID: 21208911)
MMWR Recomm Rep. 2011 Jan 21;60(1):1-24. (PMID: 21248682)
J Infect Dis. 2011 Jan 15;203(2):158-67. (PMID: 21288814)
Clin Infect Dis. 2011 Jan 1;52 Suppl 1:S183-8. (PMID: 21342893)
Blood. 2011 May 12;117(19):5050-6. (PMID: 21372154)
J Antimicrob Chemother. 2011 May;66(5):1140-9. (PMID: 21385717)
J Infect Dis. 2011 Jun 15;203(12):1739-47. (PMID: 21606532)
Semin Respir Crit Care Med. 2011 Aug;32(4):471-93. (PMID: 21858751)
Clin Infect Dis. 2011 Sep;53(6):e16-9. (PMID: 21865184)
MMWR Morb Mortal Wkly Rep. 2011 Sep 9;60(35):1193-6. (PMID: 21900872)
Pediatrics. 2011 Dec;128(6):e1450-8. (PMID: 22065262)
Clin Infect Dis. 2012 Aug;55(4):514-20. (PMID: 22573853)
BMJ Case Rep. 2010 Jul 21;2010:null. (PMID: 22767562)
Am J Respir Crit Care Med. 2013 Feb 1;187(3):276-85. (PMID: 23155145)
Intensive Care Med. 2013 Feb;39(2):275-81. (PMID: 23160769)
Antivir Ther. 2013;18(3):377-86. (PMID: 23264438)
Intensive Care Med. 2013 Oct;39(10):1704-13. (PMID: 23907497)
Dtsch Arztebl Int. 2013 Aug;110(33-34):543-9. (PMID: 24069078)
Clin Infect Dis. 2014 Jan;58(2):214-24. (PMID: 24186906)
Clin Infect Dis. 2014 Feb;58(3):e44-100. (PMID: 24311479)
Clin Respir J. 2016 Mar;10(2):223-30. (PMID: 25196245)
Crit Care. 2015 Apr 17;19:178. (PMID: 25927915)
J Infect Dis. 2015 Dec 1;212(11):1726-34. (PMID: 25985905)
Expert Opin Pharmacother. 2015;16(12):1889-900. (PMID: 26153242)
World J Crit Care Med. 2016 Feb 04;5(1):89-95. (PMID: 26855898)
Open Forum Infect Dis. 2016 Mar 08;3(1):ofw023. (PMID: 26966696)
Front Microbiol. 2016 Mar 31;7:450. (PMID: 27065996)
Am J Infect Control. 2016 Sep 1;44(9):1016-21. (PMID: 27158088)
Clin Infect Dis. 2016 Aug 15;63(4):e1-e60. (PMID: 27365388)
Am J Med Sci. 2016 Jul;352(1):81-5. (PMID: 27432039)
Infect Drug Resist. 2016 Aug 22;9:201-14. (PMID: 27578993)
Pediatr Transplant. 2017 Feb;21(1):. (PMID: 28127885)
Lancet Respir Med. 2018 Oct;6(10):782-792. (PMID: 30076119)
MMWR Recomm Rep. 2018 Aug 24;67(3):1-20. (PMID: 30141464)
J Crit Care. 2018 Dec;48:172-177. (PMID: 30216935)
Curr Opin Infect Dis. 2018 Dec;31(6):471-480. (PMID: 30299367)
J Clin Microbiol. 1983 Aug;18(2):425-7. (PMID: 6619292)
Blood. 1984 Jul;64(1):131-8. (PMID: 6733266)
Chest. 1995 Nov;108(5):1456-9. (PMID: 7587460)
J Infect Dis. 1998 Nov;178(5):1257-62. (PMID: 9780244)
فهرسة مساهمة: Keywords: Extracorporeal membrane oxygenation in immunocompromised; influenza vaccine in immunocompromised; influenza-associated aspergillosis; methicillin-resistant Staphylococcus aureus in H1N1
تواريخ الأحداث: Date Created: 20190711 Latest Revision: 20200930
رمز التحديث: 20240628
مُعرف محوري في PubMed: PMC6625244
DOI: 10.4103/lungindia.lungindia_464_18
PMID: 31290419
قاعدة البيانات: MEDLINE
الوصف
تدمد:0970-2113
DOI:10.4103/lungindia.lungindia_464_18